3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
63
Carcinoma, Non-Small-Cell Lung
60
Rectal Neoplasms
44
Glioblastoma
42
Stomach Neoplasms
37
Esophageal Neoplasms
33
Brain Neoplasms
33
Squamous Cell Carcinoma of Head and Neck
31
Colorectal Neoplasms
29
Pancreatic Neoplasms
26
Lung Neoplasms
24
Neoplasms
23
Glioma
23
Astrocytoma
22
Neoplasm Metastasis
21
Head and Neck Neoplasms
19
Sarcoma
17
Gliosarcoma
15
Esophageal Squamous Cell Carcinoma
15
Central Nervous System Neoplasms
15
Ovarian Neoplasms
14
Oligodendroglioma
13
Melanoma
13
Colonic Neoplasms
12
Adenocarcinoma Of Esophagus
12
Urinary Bladder Neoplasms
11
Prostatic Neoplasms
11
Carcinoma, Hepatocellular
11
Oropharyngeal Neoplasms
9
Carcinoma, Ovarian Epithelial
9
Interventions
Oxaliplatin
2
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
irinotecan sucrosofate
1
folfirinox
1
camrelizumab
1
Taxes
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Leucovorin
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Borderline Resectable Pancreatic Cancer
×
Surgical Procedures, Operative
×
Clear all
NCT06387810
2024-07-10
undetermined
Peking Union Medical College Hospital
Phase 2
Recruiting
45 enrolled